Industry Research Reports

Home > Reports > Medical Care > Nicotine Cessation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Nicotine Cessation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-11

Pages: 161 Pages

Report ld: 2639000

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Nicotine Cessation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Nicotine Cessation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Nicotine Cessation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Nicotine Cessation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Nicotine Cessation include GSK, Dr. Reddy's Laboratories, Cipla, Cigna, Chrono Therapeutics, Pfizer, Takeda, Achieve Life Sciences and McNeil AB, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Nicotine Cessation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nicotine Cessation by region & country, by Type, and by Application.

The Nicotine Cessation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotine Cessation.

Market Segmentation

Report Metric
Details
Report Title
Nicotine Cessation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Nicotine Cessation Companies Covered
GSK, Dr. Reddy's Laboratories, Cipla, Cigna, Chrono Therapeutics, Pfizer, Takeda, Achieve Life Sciences, McNeil AB, Ethismos, NJOY, Johnson & Johnson, JUUL Labs, Philip Morris International, VMR Products, Nicotek, Lorillard, Victory Electronic Cigarettes Corporation, Revolymer, Novartis International AG, Imperial Brands Plc
Global Nicotine Cessation Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nicotine Cessation Market, Segment by Type
Chewing Gum

Patches

Sprays and Inhalers

Others
Global Nicotine Cessation Market, Segment by Application
Hospital

Clinic

Pharmacy

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nicotine Cessation manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Nicotine Cessation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Nicotine Cessation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Nicotine Cessation Product Introduction
    1.2 Global Nicotine Cessation Market Size Forecast
    1.3 Nicotine Cessation Market Trends & Drivers
        1.3.1 Nicotine Cessation Industry Trends
        1.3.2 Nicotine Cessation Market Drivers & Opportunity
        1.3.3 Nicotine Cessation Market Challenges
        1.3.4 Nicotine Cessation Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Nicotine Cessation Players Revenue Ranking (2023)
    2.2 Global Nicotine Cessation Revenue by Company (2019-2024)
    2.3 Key Companies Nicotine Cessation Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Nicotine Cessation Product Offered
    2.5 Key Companies Time to Begin Mass Production of Nicotine Cessation
    2.6 Nicotine Cessation Market Competitive Analysis
        2.6.1 Nicotine Cessation Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Nicotine Cessation Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotine Cessation as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Chewing Gum
        3.1.2 Patches
        3.1.3 Sprays and Inhalers
        3.1.4 Others
    3.2 Global Nicotine Cessation Sales Value by Type
        3.2.1 Global Nicotine Cessation Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Nicotine Cessation Sales Value, by Type (2019-2030)
        3.2.3 Global Nicotine Cessation Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Pharmacy
        4.1.4 Others
    4.2 Global Nicotine Cessation Sales Value by Application
        4.2.1 Global Nicotine Cessation Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Nicotine Cessation Sales Value, by Application (2019-2030)
        4.2.3 Global Nicotine Cessation Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Nicotine Cessation Sales Value by Region
        5.1.1 Global Nicotine Cessation Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Nicotine Cessation Sales Value by Region (2019-2024)
        5.1.3 Global Nicotine Cessation Sales Value by Region (2025-2030)
        5.1.4 Global Nicotine Cessation Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Nicotine Cessation Sales Value, 2019-2030
        5.2.2 North America Nicotine Cessation Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Nicotine Cessation Sales Value, 2019-2030
        5.3.2 Europe Nicotine Cessation Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Nicotine Cessation Sales Value, 2019-2030
        5.4.2 Asia Pacific Nicotine Cessation Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Nicotine Cessation Sales Value, 2019-2030
        5.5.2 South America Nicotine Cessation Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Nicotine Cessation Sales Value, 2019-2030
        5.6.2 Middle East & Africa Nicotine Cessation Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Nicotine Cessation Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Nicotine Cessation Sales Value
    6.3 United States
        6.3.1 United States Nicotine Cessation Sales Value, 2019-2030
        6.3.2 United States Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Nicotine Cessation Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Nicotine Cessation Sales Value, 2019-2030
        6.4.2 Europe Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Nicotine Cessation Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Nicotine Cessation Sales Value, 2019-2030
        6.5.2 China Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Nicotine Cessation Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Nicotine Cessation Sales Value, 2019-2030
        6.6.2 Japan Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Nicotine Cessation Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Nicotine Cessation Sales Value, 2019-2030
        6.7.2 South Korea Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Nicotine Cessation Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Nicotine Cessation Sales Value, 2019-2030
        6.8.2 Southeast Asia Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Nicotine Cessation Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Nicotine Cessation Sales Value, 2019-2030
        6.9.2 India Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Nicotine Cessation Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 GSK
        7.1.1 GSK Profile
        7.1.2 GSK Main Business
        7.1.3 GSK Nicotine Cessation Products, Services and Solutions
        7.1.4 GSK Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.1.5 GSK Recent Developments
    7.2 Dr. Reddy's Laboratories
        7.2.1 Dr. Reddy's Laboratories Profile
        7.2.2 Dr. Reddy's Laboratories Main Business
        7.2.3 Dr. Reddy's Laboratories Nicotine Cessation Products, Services and Solutions
        7.2.4 Dr. Reddy's Laboratories Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.2.5 Dr. Reddy's Laboratories Recent Developments
    7.3 Cipla
        7.3.1 Cipla Profile
        7.3.2 Cipla Main Business
        7.3.3 Cipla Nicotine Cessation Products, Services and Solutions
        7.3.4 Cipla Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.3.5 Cigna Recent Developments
    7.4 Cigna
        7.4.1 Cigna Profile
        7.4.2 Cigna Main Business
        7.4.3 Cigna Nicotine Cessation Products, Services and Solutions
        7.4.4 Cigna Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.4.5 Cigna Recent Developments
    7.5 Chrono Therapeutics
        7.5.1 Chrono Therapeutics Profile
        7.5.2 Chrono Therapeutics Main Business
        7.5.3 Chrono Therapeutics Nicotine Cessation Products, Services and Solutions
        7.5.4 Chrono Therapeutics Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.5.5 Chrono Therapeutics Recent Developments
    7.6 Pfizer
        7.6.1 Pfizer Profile
        7.6.2 Pfizer Main Business
        7.6.3 Pfizer Nicotine Cessation Products, Services and Solutions
        7.6.4 Pfizer Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.6.5 Pfizer Recent Developments
    7.7 Takeda
        7.7.1 Takeda Profile
        7.7.2 Takeda Main Business
        7.7.3 Takeda Nicotine Cessation Products, Services and Solutions
        7.7.4 Takeda Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.7.5 Takeda Recent Developments
    7.8 Achieve Life Sciences
        7.8.1 Achieve Life Sciences Profile
        7.8.2 Achieve Life Sciences Main Business
        7.8.3 Achieve Life Sciences Nicotine Cessation Products, Services and Solutions
        7.8.4 Achieve Life Sciences Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.8.5 Achieve Life Sciences Recent Developments
    7.9 McNeil AB
        7.9.1 McNeil AB Profile
        7.9.2 McNeil AB Main Business
        7.9.3 McNeil AB Nicotine Cessation Products, Services and Solutions
        7.9.4 McNeil AB Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.9.5 McNeil AB Recent Developments
    7.10 Ethismos
        7.10.1 Ethismos Profile
        7.10.2 Ethismos Main Business
        7.10.3 Ethismos Nicotine Cessation Products, Services and Solutions
        7.10.4 Ethismos Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.10.5 Ethismos Recent Developments
    7.11 NJOY
        7.11.1 NJOY Profile
        7.11.2 NJOY Main Business
        7.11.3 NJOY Nicotine Cessation Products, Services and Solutions
        7.11.4 NJOY Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.11.5 NJOY Recent Developments
    7.12 Johnson & Johnson
        7.12.1 Johnson & Johnson Profile
        7.12.2 Johnson & Johnson Main Business
        7.12.3 Johnson & Johnson Nicotine Cessation Products, Services and Solutions
        7.12.4 Johnson & Johnson Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.12.5 Johnson & Johnson Recent Developments
    7.13 JUUL Labs
        7.13.1 JUUL Labs Profile
        7.13.2 JUUL Labs Main Business
        7.13.3 JUUL Labs Nicotine Cessation Products, Services and Solutions
        7.13.4 JUUL Labs Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.13.5 JUUL Labs Recent Developments
    7.14 Philip Morris International
        7.14.1 Philip Morris International Profile
        7.14.2 Philip Morris International Main Business
        7.14.3 Philip Morris International Nicotine Cessation Products, Services and Solutions
        7.14.4 Philip Morris International Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.14.5 Philip Morris International Recent Developments
    7.15 VMR Products
        7.15.1 VMR Products Profile
        7.15.2 VMR Products Main Business
        7.15.3 VMR Products Nicotine Cessation Products, Services and Solutions
        7.15.4 VMR Products Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.15.5 VMR Products Recent Developments
    7.16 Nicotek
        7.16.1 Nicotek Profile
        7.16.2 Nicotek Main Business
        7.16.3 Nicotek Nicotine Cessation Products, Services and Solutions
        7.16.4 Nicotek Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.16.5 Nicotek Recent Developments
    7.17 Lorillard
        7.17.1 Lorillard Profile
        7.17.2 Lorillard Main Business
        7.17.3 Lorillard Nicotine Cessation Products, Services and Solutions
        7.17.4 Lorillard Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.17.5 Lorillard Recent Developments
    7.18 Victory Electronic Cigarettes Corporation
        7.18.1 Victory Electronic Cigarettes Corporation Profile
        7.18.2 Victory Electronic Cigarettes Corporation Main Business
        7.18.3 Victory Electronic Cigarettes Corporation Nicotine Cessation Products, Services and Solutions
        7.18.4 Victory Electronic Cigarettes Corporation Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.18.5 Victory Electronic Cigarettes Corporation Recent Developments
    7.19 Revolymer
        7.19.1 Revolymer Profile
        7.19.2 Revolymer Main Business
        7.19.3 Revolymer Nicotine Cessation Products, Services and Solutions
        7.19.4 Revolymer Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.19.5 Revolymer Recent Developments
    7.20 Novartis International AG
        7.20.1 Novartis International AG Profile
        7.20.2 Novartis International AG Main Business
        7.20.3 Novartis International AG Nicotine Cessation Products, Services and Solutions
        7.20.4 Novartis International AG Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.20.5 Novartis International AG Recent Developments
    7.21 Imperial Brands Plc
        7.21.1 Imperial Brands Plc Profile
        7.21.2 Imperial Brands Plc Main Business
        7.21.3 Imperial Brands Plc Nicotine Cessation Products, Services and Solutions
        7.21.4 Imperial Brands Plc Nicotine Cessation Revenue (US$ Million) & (2019-2024)
        7.21.5 Imperial Brands Plc Recent Developments

 8 Industry Chain Analysis
    8.1 Nicotine Cessation Industrial Chain
    8.2 Nicotine Cessation Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Nicotine Cessation Sales Model
        8.5.2 Sales Channel
        8.5.3 Nicotine Cessation Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Nicotine Cessation Market Trends
    Table 2. Nicotine Cessation Market Drivers & Opportunity
    Table 3. Nicotine Cessation Market Challenges
    Table 4. Nicotine Cessation Market Restraints
    Table 5. Global Nicotine Cessation Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Nicotine Cessation Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Nicotine Cessation Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Nicotine Cessation Product Type
    Table 9. Key Companies Time to Begin Mass Production of Nicotine Cessation
    Table 10. Global Nicotine Cessation Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotine Cessation as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Nicotine Cessation Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Nicotine Cessation Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Nicotine Cessation Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Nicotine Cessation Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Nicotine Cessation Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Nicotine Cessation Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Nicotine Cessation Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Nicotine Cessation Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Nicotine Cessation Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Nicotine Cessation Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Nicotine Cessation Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Nicotine Cessation Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Nicotine Cessation Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Nicotine Cessation Sales Value by Region (2019-2024) & (%)
    Table 27. Global Nicotine Cessation Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Nicotine Cessation Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Nicotine Cessation Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Nicotine Cessation Sales Value, (2025-2030) & (US$ Million)
    Table 31. GSK Basic Information List
    Table 32. GSK Description and Business Overview
    Table 33. GSK Nicotine Cessation Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Nicotine Cessation Business of GSK (2019-2024)
    Table 35. GSK Recent Developments
    Table 36. Dr. Reddy's Laboratories Basic Information List
    Table 37. Dr. Reddy's Laboratories Description and Business Overview
    Table 38. Dr. Reddy's Laboratories Nicotine Cessation Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Nicotine Cessation Business of Dr. Reddy's Laboratories (2019-2024)
    Table 40. Dr. Reddy's Laboratories Recent Developments
    Table 41. Cipla Basic Information List
    Table 42. Cipla Description and Business Overview
    Table 43. Cipla Nicotine Cessation Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Nicotine Cessation Business of Cipla (2019-2024)
    Table 45. Cipla Recent Developments
    Table 46. Cigna Basic Information List
    Table 47. Cigna Description and Business Overview
    Table 48. Cigna Nicotine Cessation Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Nicotine Cessation Business of Cigna (2019-2024)
    Table 50. Cigna Recent Developments
    Table 51. Chrono Therapeutics Basic Information List
    Table 52. Chrono Therapeutics Description and Business Overview
    Table 53. Chrono Therapeutics Nicotine Cessation Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Nicotine Cessation Business of Chrono Therapeutics (2019-2024)
    Table 55. Chrono Therapeutics Recent Developments
    Table 56. Pfizer Basic Information List
    Table 57. Pfizer Description and Business Overview
    Table 58. Pfizer Nicotine Cessation Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Nicotine Cessation Business of Pfizer (2019-2024)
    Table 60. Pfizer Recent Developments
    Table 61. Takeda Basic Information List
    Table 62. Takeda Description and Business Overview
    Table 63. Takeda Nicotine Cessation Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Nicotine Cessation Business of Takeda (2019-2024)
    Table 65. Takeda Recent Developments
    Table 66. Achieve Life Sciences Basic Information List
    Table 67. Achieve Life Sciences Description and Business Overview
    Table 68. Achieve Life Sciences Nicotine Cessation Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Nicotine Cessation Business of Achieve Life Sciences (2019-2024)
    Table 70. Achieve Life Sciences Recent Developments
    Table 71. McNeil AB Basic Information List
    Table 72. McNeil AB Description and Business Overview
    Table 73. McNeil AB Nicotine Cessation Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Nicotine Cessation Business of McNeil AB (2019-2024)
    Table 75. McNeil AB Recent Developments
    Table 76. Ethismos Basic Information List
    Table 77. Ethismos Description and Business Overview
    Table 78. Ethismos Nicotine Cessation Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Nicotine Cessation Business of Ethismos (2019-2024)
    Table 80. Ethismos Recent Developments
    Table 81. NJOY Basic Information List
    Table 82. NJOY Description and Business Overview
    Table 83. NJOY Nicotine Cessation Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Nicotine Cessation Business of NJOY (2019-2024)
    Table 85. NJOY Recent Developments
    Table 86. Johnson & Johnson Basic Information List
    Table 87. Johnson & Johnson Description and Business Overview
    Table 88. Johnson & Johnson Nicotine Cessation Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Nicotine Cessation Business of Johnson & Johnson (2019-2024)
    Table 90. Johnson & Johnson Recent Developments
    Table 91. JUUL Labs Basic Information List
    Table 92. JUUL Labs Description and Business Overview
    Table 93. JUUL Labs Nicotine Cessation Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Nicotine Cessation Business of JUUL Labs (2019-2024)
    Table 95. JUUL Labs Recent Developments
    Table 96. Philip Morris International Basic Information List
    Table 97. Philip Morris International Description and Business Overview
    Table 98. Philip Morris International Nicotine Cessation Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Nicotine Cessation Business of Philip Morris International (2019-2024)
    Table 100. Philip Morris International Recent Developments
    Table 101. VMR Products Basic Information List
    Table 102. VMR Products Description and Business Overview
    Table 103. VMR Products Nicotine Cessation Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Nicotine Cessation Business of VMR Products (2019-2024)
    Table 105. VMR Products Recent Developments
    Table 106. Nicotek Basic Information List
    Table 107. Nicotek Description and Business Overview
    Table 108. Nicotek Nicotine Cessation Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Nicotine Cessation Business of Nicotek (2019-2024)
    Table 110. Nicotek Recent Developments
    Table 111. Lorillard Basic Information List
    Table 112. Lorillard Description and Business Overview
    Table 113. Lorillard Nicotine Cessation Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Nicotine Cessation Business of Lorillard (2019-2024)
    Table 115. Lorillard Recent Developments
    Table 116. Victory Electronic Cigarettes Corporation Basic Information List
    Table 117. Victory Electronic Cigarettes Corporation Description and Business Overview
    Table 118. Victory Electronic Cigarettes Corporation Nicotine Cessation Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Nicotine Cessation Business of Victory Electronic Cigarettes Corporation (2019-2024)
    Table 120. Victory Electronic Cigarettes Corporation Recent Developments
    Table 121. Revolymer Basic Information List
    Table 122. Revolymer Description and Business Overview
    Table 123. Revolymer Nicotine Cessation Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Nicotine Cessation Business of Revolymer (2019-2024)
    Table 125. Revolymer Recent Developments
    Table 126. Novartis International AG Basic Information List
    Table 127. Novartis International AG Description and Business Overview
    Table 128. Novartis International AG Nicotine Cessation Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Nicotine Cessation Business of Novartis International AG (2019-2024)
    Table 130. Novartis International AG Recent Developments
    Table 131. Imperial Brands Plc Basic Information List
    Table 132. Imperial Brands Plc Description and Business Overview
    Table 133. Imperial Brands Plc Nicotine Cessation Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Nicotine Cessation Business of Imperial Brands Plc (2019-2024)
    Table 135. Imperial Brands Plc Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Nicotine Cessation Downstream Customers
    Table 139. Nicotine Cessation Distributors List
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
    Table 143. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Nicotine Cessation Product Picture
    Figure 2. Global Nicotine Cessation Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Nicotine Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 4. Nicotine Cessation Report Years Considered
    Figure 5. Global Nicotine Cessation Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Nicotine Cessation Revenue in 2023
    Figure 7. Nicotine Cessation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Chewing Gum Picture
    Figure 9. Patches Picture
    Figure 10. Sprays and Inhalers Picture
    Figure 11. Others Picture
    Figure 12. Global Nicotine Cessation Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Nicotine Cessation Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospital
    Figure 15. Product Picture of Clinic
    Figure 16. Product Picture of Pharmacy
    Figure 17. Product Picture of Others
    Figure 18. Global Nicotine Cessation Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Nicotine Cessation Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Nicotine Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Nicotine Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Nicotine Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Nicotine Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Nicotine Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Nicotine Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Nicotine Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Nicotine Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Nicotine Cessation Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Nicotine Cessation Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Nicotine Cessation Sales Value (%), (2019-2030)
    Figure 31. United States Nicotine Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Nicotine Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Nicotine Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Nicotine Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Nicotine Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Nicotine Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Nicotine Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Nicotine Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Nicotine Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Nicotine Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Nicotine Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Nicotine Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Nicotine Cessation Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Nicotine Cessation Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Nicotine Cessation Sales Value by Application (%), 2023 VS 2030
    Figure 52. Nicotine Cessation Industrial Chain
    Figure 53. Nicotine Cessation Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation

Description

The global market for Nicotine Cessation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Nicotine Cessation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Nicotine Cessation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Nicotine Cessation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Nicotine Cessation include GSK, Dr. Reddy's Laboratories, Cipla, Cigna, Chrono Therapeutics, Pfizer, Takeda, Achieve Life Sciences and McNeil AB, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Nicotine Cessation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nicotine Cessation by region & country, by Type, and by Application.

The Nicotine Cessation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotine Cessation.

Market Segmentation